OPTIMA (Optimizing Prograf Therapy in Renal Transplant Patients)

Trial Profile

OPTIMA (Optimizing Prograf Therapy in Renal Transplant Patients)

Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2008

At a glance

  • Drugs Ciclosporin; Tacrolimus
  • Indications Renal transplant rejection; Transplant rejection
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms OPTIMA
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 22 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 25 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top